Northwestern Medicine Selects Tempus to Expand Genomic Testing
Collaboration will focus on the oncology patient population CHICAGO, January 12, 2026–(BUSINESS WIRE)–Northwestern Medicine and Tempus AI, Inc.…
Genetic Testing Enables Tailored Treatments, Better Outcomes
Q: What solutions does OncoAtlas bring to patients and health professionals? A: OncoAtlas is a science-based company that…